Stepan Company (SCL)

NYSE Materials Specialty Chemicals S&P SmallCap 600
$66.94
-0.91 (-1.34%)
Close of Nov 06, 2026 · end-of-day data
SMA 50SMA 2005Y/10Y use weekly candles (10/40-week averages)

Performance

price return
1W-3.8%
1M+9.7%
3M+3.2%
6M+26.5%
YTD+41.3%
1Y+52.5%
3Y-9.6%
5Y-44.2%

Key statistics

Full financials →
Market cap$1.5B
P/E (TTM)352.3
EPS (TTM, diluted)$0.19
P/S0.60
P/B1.25
EV / EBITDA13.5
Revenue (TTM)$2.54B
Revenue growth+10.0%
Net margin0.2%
ROE0.4%
Debt / equity0.52
FCF yield0.3%
Dividend yield2.36%
Payout ratio832%
Beta (1Y)0.68
Volatility (1Y)37.6%
52-week range$42.14 – $72.67
Avg volume (50D)159.41K

Revenue & net income — last 8 quarters

Statements →
Oct 28, 7:00 AM ET

Stepan Q3 Net Income Rises 64% to $17.8 Million; Quarterly Dividend Raised to $0.405

Mixed earnings 2.028.01

Stepan reported third quarter 2026 net sales of $692.2 million, up 17%, and net income of $17.8 million, up 64%, with diluted EPS of $0.78 versus $0.47. Nine-month results were a net loss of $0.7 million because of a $76.1 million pre-tax restructuring charge tied to Project Catalyst, and the company said it expects full-year Adjusted EBITDA growth and positive free cash flow in 2026. The board also declared a $0.405 quarterly dividend, a $0.010 increase.

  • Q3 2026 net sales $692.2 million, up 17% year-over-year; Q3 Adjusted EBITDA $66.3 million, up 18%
  • Nine months 2026 net loss of $0.7 million versus $41.9 million of income in 2025, driven by a $76.1 million pre-tax restructuring charge
  • Quarterly dividend of $0.405 per share, payable December 15, 2026, to holders of record on December 1, 2026; 59th consecutive annual increase
  • Company expects full-year 2026 Adjusted EBITDA growth, positive free cash flow and continued balance sheet de-leveraging
Read the filing on SEC.gov ↗
Sep 25, 9:47 PM ET

Stepan Co. signs $500 million credit agreement maturing in 2031, replacing older facilities

Neutral financing Written later 1.012.03

Stepan entered into a new Credit Agreement on September 25, 2026, providing $500.0 million in initial committed facilities: a $350.0 million multicurrency revolver and a $150.0 million delayed draw term loan, both maturing September 25, 2031. The new facilities replace its $350.0 million revolver and $100.0 million delayed draw term loan under a June 24, 2022 agreement, and include an option for up to an additional $250.0 million, giving the company expanded, longer-dated borrowing capacity.

  • Initial facilities total $500.0 million: $350.0 million revolver and $150.0 million delayed draw term loan, both maturing September 25, 2031
  • Replaces the $350.0 million revolver and $100.0 million delayed draw term loan from a June 24, 2022 credit agreement
  • Expansion option allows up to an additional $250.0 million, subject to certain requirements
  • Loans priced at spreads of 1.125% to 1.625% over term benchmark rates, depending on net leverage ratio; covenants include interest coverage and net leverage ratios
Read the filing on SEC.gov ↗
Jul 29, 7:00 AM ET

Stepan Q2 net income up 102% to $22.9 million; first-half loss on $70.5 million charge

Mixed earnings Written later 2.022.055.028.01

Stepan reported second-quarter 2026 net income of $22.9 million, up 102% from a year earlier, on net sales of $684.1 million, up 15%. The first half was a net loss of $18.5 million, driven by a $70.5 million pre-tax restructuring charge tied to Project Catalyst, and the company also announced a plan to cut about 100 salaried roles, declared a $0.395 quarterly dividend, and reported a board resignation and a new principal accounting officer.

  • Q2 2026 diluted EPS was $1.00 versus $0.50; adjusted EPS was $1.18 versus $0.52.
  • Q2 adjusted EBITDA was $74.4 million, up 45%, and management said it expects full-year 2026 adjusted EBITDA growth.
  • Full-year Project Catalyst restructuring charges are expected to be $75.0 million to $80.0 million, with about $4 million to $6 million tied to the workforce reduction.
  • Jan Stern Reed resigned from the board on July 27, 2026; Matthew J. Eaken was named principal accounting officer effective July 28, 2026.
Read the filing on SEC.gov ↗
Apr 28, 7:00 AM ET

Stepan posts $41.4 million Q1 loss on $65.4 million restructuring charge

Mixed earnings Written later 2.028.01

Stepan Company reported a first-quarter 2026 net loss of $41.4 million, or $1.81 per diluted share, compared with net income of $19.7 million a year earlier, after a $65.4 million pre-tax restructuring charge tied to previously announced plant closures. Net sales rose 2% to $604.5 million, but adjusted net income fell 47% to $10.3 million, and the company also declared a quarterly dividend of $0.395 per share.

  • Net loss of $41.4 million ($1.81 per diluted share) versus net income of $19.7 million ($0.86 per share) in Q1 2025; the loss includes a $65.4 million pre-tax restructuring charge
  • Adjusted net income of $10.3 million ($0.45 per diluted share), down 47% from $19.3 million; adjusted EBITDA of $49.6 million, down 14%
  • Net sales rose 2% to $604.5 million, driven by higher selling prices and currency translation; organic sales volume was flat
  • Board declared a quarterly dividend of $0.395 per share, payable June 15, 2026, to holders of record on June 1, 2026
Read the filing on SEC.gov ↗

Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.

Insider transactions

All insider trades →
DateInsiderTypeSharesPriceValue
May 11Weitkamp Robin Joseph
SVP and GM Surfactants-INT
Option Exercise140$52.58$7.36K
Nov 03Stepan F Quinn Jr
Director
Gift1.43K—$0

Prices are end-of-day and split-adjusted. Financial data from Stepan Company's SEC XBRL filings. Not investment advice.